no statement of use filed
on 15 Jan 2018
Last Applicant/ Owned by
980 Great West Road
Brentford, Middlesex
GB
TW89GS
Serial Number
86283256 filed on 16th May 2014
Registration Number
N/A
Correspondent Address
ANGELA L. WILSON
GlaxoSmithKline
Five Moore Drive
Legal Global Trademarks, Mailstop: 5.5A
Research Triangle Park, NC 27709-0183
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonRead More
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
No 86283256
No Service/Collective Mark
No TMID/5098636
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th Jan 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
15th Jan 2018 | ABANDONMENT - NO USE STATEMENT FILED |
08th Jun 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
07th Jun 2017 | EXTENSION 5 GRANTED |
06th Jun 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
30th May 2017 | EXTENSION 5 FILED |
30th May 2017 | TEAS EXTENSION RECEIVED |
13th Dec 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Dec 2016 | EXTENSION 4 GRANTED |
01st Dec 2016 | TEAS EXTENSION RECEIVED |